RA
TDOC icon

Royce & Associates’s Teladoc Health TDOC Stock Holding History

Royce & Associates’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Buy
+12,912
New +$85.9K ﹤0.01% 732
2024
Q4 		– Sell
-18,189
Closed -$167K – 902
2024
Q3 		$167K Buy
+18,189
New +$151K ﹤0.01% 839

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Royce & Associates's TDOC Position: Q2 2026 in Review

Royce & Associates opened a new position in Teladoc Health (TDOC) in Q2 2026: 12,912 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #732 among its holdings. This is a return to the name: Royce & Associates previously reported a position in TDOC as recently as Q3 2024.

Royce & Associates first reported a position in TDOC in Q3 2024 and has held it in 2 quarters since. The position peaked at $167K in Q3 2024. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Royce & Associates held 12,912 shares of Teladoc Health worth $109K as of Q2 2026.
  • Teladoc Health was a new Royce & Associates position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Royce & Associates's portfolio in Q2 2026, its #732 holding.
  • Royce & Associates first reported a position in Teladoc Health in Q3 2024 and has held it in 2 quarters since.
  • Royce & Associates's Teladoc Health position peaked at $167K in Q3 2024.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.